Cargando…

Kinetic analysis and optimisation of (18)F-rhPSMA-7.3 PET imaging of prostate cancer

PURPOSE: This phase 1 open-label study evaluated the uptake kinetics of a novel theranostic PET radiopharmaceutical, (18)F-rhPSMA-7.3, to optimise its use for imaging of prostate cancer. METHODS: Nine men, three with high-risk localised prostate cancer, three with treatment-naïve hormone-sensitive m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malaspina, Simona, Oikonen, Vesa, Kuisma, Anna, Ettala, Otto, Mattila, Kalle, Boström, Peter J., Minn, Heikki, Kalliokoski, Kari, Postema, Ernst J., Miller, Matthew P., Scheinin, Mika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440272/ https://www.ncbi.nlm.nih.gov/pubmed/33846844 http://dx.doi.org/10.1007/s00259-021-05346-8

Ejemplares similares

Safety, Biodistribution, and Radiation Dosimetry of (18)F-rhPSMA-7.3 in Healthy Adult Volunteers
por: Tolvanen, Tuula, et al.
Publicado: (2021)

Preclinical biodistribution and dosimetry and human biodistribution comparing (18)F-rhPSMA-7 and single isomer (18)F-rhPSMA-7.3
por: Knorr, Karina, et al.
Publicado: (2022)

Pitfalls in PSMA imaging: [(18)F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
por: Feuerecker, B., et al.
Publicado: (2021)

Automated synthesis of [(18)F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions
por: Wurzer, Alexander, et al.
Publicado: (2021)

Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on (18)F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer
por: Notohamiprodjo, Susan, et al.
Publicado: (2022)

A rare case of polyostotic fibrous dysplasia detected on (18)F-rhPSMA-7 PET/CT
por: Wang, Hui, et al.
Publicado: (2020)

Preclinical comparison of four [(18)F, (nat)Ga]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics
por: Wurzer, Alexander, et al.
Publicado: (2020)

Glioblastoma PET/MRI: kinetic investigation of [(18)F]rhPSMA-7.3, [(18)F]FET and [(18)F]fluciclovine in an orthotopic mouse model of cancer
por: Lindemann, Marcel, et al.
Publicado: (2022)

Radiohybrid Ligands: A Novel Tracer Concept Exemplified by (18)F- or (68)Ga-Labeled rhPSMA Inhibitors
por: Wurzer, Alexander, et al.
Publicado: (2020)

(177)Lu-rhPSMA-10.1 Induces Tumor Response in a Patient With mCRPC After PSMA-Directed Radioligand Therapy With (177)Lu-PSMA-I&T
por: Bundschuh, Ralph A., et al.
Publicado: (2023)

Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with (68)Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer
por: Ettala, Otto, et al.
Publicado: (2019)

Flare on [(18)F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients
por: Malaspina, Simona, et al.
Publicado: (2022)

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
por: MATTILA, Kalle, et al.
Publicado: (2023)

Myocardial Blood Flow and Metabolic Rate of Oxygen Measurement in the Right and Left Ventricles at Rest and During Exercise Using (15)O-Labeled Compounds and PET
por: Kudomi, Nobuyuki, et al.
Publicado: (2019)

Prediction of prostate cancer aggressiveness using (18)F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
por: Movahedi, Parisa, et al.
Publicado: (2020)

Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
por: Lundmark, Fanny, et al.
Publicado: (2022)

Prospective comparison of (18)F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
por: Malaspina, Simona, et al.
Publicado: (2021)

(11)C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
por: Salminen, Antti, et al.
Publicado: (2018)

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma
por: Mattila, Kalle E., et al.
Publicado: (2021)

Correlation between (18)F-1-amino-3-fluorocyclobutane-1-carboxylic acid ((18)F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer
por: Saarinen, Irena, et al.
Publicado: (2019)

More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond
por: Hyväkkä, Anniina, et al.
Publicado: (2021)

Radium‐223 dichloride treatment in metastatic castration‐resistant prostate cancer in Finland: A real‐world evidence multicenter study
por: Hyväkkä, Anniina, et al.
Publicado: (2022)

Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study
por: Salmivalli, Alisa, et al.
Publicado: (2022)

Comparison of: (2S,4R)-4-[(18)F]Fluoroglutamine, [(11)C]Methionine, and 2-Deoxy-2-[(18)F]Fluoro-D-Glucose and Two Small-Animal PET/CT Systems Imaging Rat Gliomas
por: Miner, Maxwell W. G., et al.
Publicado: (2021)

Heterobivalent Agents Targeting PSMA and Integrin-α(v)β(3)
por: Shallal, Hassan M., et al.
Publicado: (2014)

Gene expression profiles and signaling mechanisms in α(2B)-adrenoceptor-evoked proliferation of vascular smooth muscle cells
por: Huhtinen, Anna, et al.
Publicado: (2017)

Validation of automated magnetic resonance image segmentation for radiation therapy planning in prostate cancer
por: Kuisma, Anna, et al.
Publicado: (2020)

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
por: Chen, Ying, et al.
Publicado: (2022)

Muscle Free Fatty-Acid Uptake Associates to Mechanical Efficiency During Exercise in Humans
por: Laaksonen, Marko S., et al.
Publicado: (2018)

Deep Learning Method for Mandibular Canal Segmentation in Dental Cone Beam Computed Tomography Volumes
por: Jaskari, Joel, et al.
Publicado: (2020)

TAp73 enhances the pentose phosphate pathway and supports cell proliferation
por: Du, Wenjing, et al.
Publicado: (2013)

Short- and long-term risks of photoselective laser vaporization of the prostate: a population-based comparison with transurethral resection of the prostate
por: Salmivalli, Alisa, et al.
Publicado: (2023)

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression
por: Yu, Lan, et al.
Publicado: (2022)

Value of Combined PET Imaging with [(18)F]FDG and [(68)Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [(177)Lu]Lu-PSMA-617 RLT
por: Khreish, Fadi, et al.
Publicado: (2021)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
por: Staniszewska, Magdalena, et al.
Publicado: (2021)

Purely ropivacaine-based TEA vs single TAP block in pain management after elective laparoscopic colon surgery within an upgraded institutional ERAS program
por: Bumblyte, Vilma, et al.
Publicado: (2021)

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
por: Minn, Il, et al.
Publicado: (2019)

(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2017)

Nuclear Translocation of Crk Adaptor Proteins by the Influenza A Virus NS1 Protein
por: Ylösmäki, Leena, et al.
Publicado: (2016)

PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
por: Bychkov, Andrey, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pm1fmpthjhr1635077k41nfbtu